Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 1.9313.469.084.921.50

What is the latest Core EBITDA Margin ratio of VAISHALI PHARMA ?

The latest Core EBITDA Margin ratio of VAISHALI PHARMA is 1.93 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20241.93
Mar202313.46
Mar20229.08
Mar20214.92
Mar20201.50

How is Core EBITDA Margin of VAISHALI PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 1.93
-85.66
Mar2023 13.46
48.24
Mar2022 9.08
84.55
Mar2021 4.92
228.00
Mar2020 1.5 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Margin ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹207.0 Cr -8% 4.8% 0.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr -2% -0.8% 16.6% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr -2.7% 3.5% 66.7% Stock Analytics
CIPLA ₹117,778.0 Cr 0.7% 1.4% 3.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 0.1% -8.5% 0.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr -0.9% -1% 24% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-8%

4.8%

0.5%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses